Siberian State Medical University concluded a memorandum of cooperation with AstraZeneca Russia
On February 8, 2016 (the official Day of Russian Science) SSMU and the international biopharmaceutical company AstraZeneca concluded a memorandum of cooperation. The parties now intend to develop scientific, academic, and cultural partnership in order to enhance the efficiency of the public health service.One of the key areas of this cooperation is developing strategies for early detection and innovative treatment of type 2 diabetes.
“Our university is accreditedto conduct clinical research (phases I-IV) and clinical trials of Russian medical devices. We are honored to have established cooperation with leading Russian and foreign pharmaceutical companies and contract research organizations. For many years,SSMU scientists have been conducting scientific research to develop new methods of diagnostics and treatment of type 2 diabetes. I am certain that the collaborative work with AstraZenecawill promote the integration ofadvanced approaches to treatment. It will also integrate Russian investigations into the world’s medical science”, said Olga S. Kobyakova, Rector of SSMU.
In the framework of this cooperation, SSMU and AstraZeneca aim to exchange scientific information, conduct collaborative research, and undertake training and upgrading activities for doctors.
“The partnership with one of the leading Russian educational and scientific centersis very valuable for us. The company’s long-standing experience in development and integration of innovative treatment techniques of socially significant diseases along with the scientific basis and the examination by talented scientists from SSMUwill certainly help the development of modern medicine, and also benefit the patients”, explained Kristina Rodnikova, Area Vice President, AstraZeneca Russia & Eurasia.
Siberian State Medical University is among top three Russian medical universities. Its history dates back to 1888. The large scientific, educational and clinical center, SSMU today includes six departments with over 5,000 students, Medical-Pharmaceutical College, central research laboratory, simulation center of the European level, multidisciplinary clinics that provide treatment to over 15,000 patients annually. SSMU is the leader in the number of state-funded places among medical universities beyond the Urals.
AstraZeneca is an international innovative biopharmaceutical company that is aimed at researching, developing and commercializing of prescription medicines in different therapeutic areas, including cardiology, endocrinology, oncology, respiratory diseases and inflammatory processes, infections, and psychiatry. The company operates in over 100 countries and its innovative medicines are used by millions of patients worldwide.